Scottish university spinouts raised significantly less per company than equivalent spinouts from English institutions last year, according to figures reported by The Scotsman, with the funding gap between Scotland and the so-called Golden Triangle of London, Oxford, and Cambridge growing wider. For a country that hosts four of the UK's top twenty universities and produces research output well above its population share, that is not a talent problem. It is a capital infrastructure problem.
The numbers are stark. Research from Beauhurst, which tracks private company growth in the UK, shows that Scottish spinouts consistently underperform their southern peers at seed and Series A stage, the rounds that determine whether a company survives long enough to scale. Scottish Enterprise and Highlands and Islands Enterprise both run programmes designed to plug exactly this gap, including the Scottish National Investment Bank's early-stage co-investment fund, but institutional investors still concentrate capital in postcodes they know, and most of them live in EC1 and W1, not EH1.
Part of the problem is structural. UK venture capital remains geographically concentrated to a degree that embarrasses most international comparisons. According to the British Business Bank's 2023 Nations and Regions report, Scotland received around 7% of UK venture investment despite accounting for roughly 8.2% of the population and a disproportionately large share of university research output. That sounds close, until you account for the fact that spinouts, which carry embedded IP and typically have longer development timelines, require patient, specialist capital that Scottish institutional investors are still building the capacity to deploy at scale.
The Scottish Government's AI Strategy and its broader innovation framework explicitly target this weakness, and the Scottish National Investment Bank was created in part to address it. But the Bank operates in a market still shaped by London proximity, relationship networks, and the gravitational pull of investor communities that have not yet built meaningful presence in Glasgow or Edinburgh. Scottish EDGE, one of the most effective early-stage funding competitions in the UK, fills part of the gap at micro-scale, but it cannot substitute for the mid-sized venture rounds that let a spinout move from proof-of-concept to commercial traction.
There is a sharper version of this story, and it involves policy choices made at Westminster level. Research and Development tax credit structures, the Enterprise Investment Scheme, and Innovate UK grant allocation have all, at various points, been designed in ways that disadvantage companies outside the south-east of England, whether through location requirements, network access, or administrative burden that falls harder on smaller teams. The University of Edinburgh's commercialisation office, Edinburgh Innovations, has been vocal about this asymmetry, and similar concerns have been raised by spinout founders at Strathclyde, Dundee, and St Andrews. Scotland is generating the science. The question is who captures the economic return from it, and where that return lands.
For Edinburgh-based founders and SME owners adjacent to the university ecosystem, the practical implication is this: if you are building on research, or thinking about licensing IP from a Scottish institution, the funding environment is harder than it should be, but it is not empty. The Scottish National Investment Bank, Scottish Enterprise's Co-Investment Fund, and programmes like Techscaler, the Scottish Government's national tech accelerator, are real routes to early capital. The gap is not in ambition or in the quality of Scottish science. It is in the pipeline of investor relationships that turn good research into fundable, scalable companies, and that pipeline is what needs building urgently.